Plexus (NASDAQ:PLXS – Get Free Report) released its quarterly earnings data on Wednesday. The technology company reported $1.49 EPS for the quarter, missing the consensus estimate of $1.59 by ($0.10), Zacks reports. Plexus had a net margin of 3.03% and a return on equity of 10.43%. Plexus updated its Q2 2025 guidance to 1.460-1.610 EPS.
Plexus Stock Performance
Shares of Plexus stock opened at $153.30 on Friday. The company has a quick ratio of 0.71, a current ratio of 1.51 and a debt-to-equity ratio of 0.07. The stock’s fifty day moving average is $162.30 and its two-hundred day moving average is $141.25. Plexus has a 52 week low of $90.18 and a 52 week high of $172.89. The company has a market capitalization of $4.15 billion, a PE ratio of 35.57 and a beta of 0.91.
Insider Transactions at Plexus
In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $156.39, for a total value of $234,585.00. Following the completion of the sale, the chief executive officer now directly owns 74,271 shares in the company, valued at approximately $11,615,241.69. This represents a 1.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Michael J. Running sold 539 shares of the firm’s stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $155.87, for a total transaction of $84,013.93. Following the transaction, the insider now directly owns 1,030 shares in the company, valued at $160,546.10. This trade represents a 34.35 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 34,091 shares of company stock worth $5,377,960. 1.76% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
View Our Latest Report on PLXS
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
See Also
- Five stocks we like better than Plexus
- Investing In Preferred Stock vs. Common Stock
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- 3 Monster Growth Stocks to Buy Now
- 3 Buy-and-Hold Stocks for Long-Term Growth
- How to Use Stock Screeners to Find Stocks
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.